V. Golubkov

发表

Cellular Membrane Type-1 Matrix Metalloproteinase (MT1-MMP) Cleaves C3b, an Essential Component of the Complement System*

A. Strongin, A. Remacle, D. Rozanov, 2004, Journal of Biological Chemistry.

Protein-tyrosine Pseudokinase 7 (PTK7) Directs Cancer Cell Motility and Metastasis*

A. Strongin, R. Hoffman, N. Prigozhina, 2014, The Journal of Biological Chemistry.

SAR Studies of Exosite-Binding Substrate-Selective Inhibitors of A Disintegrin And Metalloprotease 17 (ADAM17) and Application as Selective in Vitro Probes.

M. Giulianotti, R. Houghten, R. Fridman, 2015, Journal of medicinal chemistry.

Wild‐type amyloid beta 1‐40 peptide induces vascular smooth muscle cell death independently from matrix metalloprotease activity

G. Béréziat, V. Golubkov, I. Limon, 2012, Aging cell.

O-Glycosylation Regulates Autolysis of Cellular Membrane Type-1 Matrix Metalloproteinase (MT1-MMP)*

A. Strongin, A. Remacle, D. Rozanov, 2006, Journal of Biological Chemistry.

Engineering a leucine zipper-TRAIL homotrimer with improved cytotoxicity in tumor cells

A. Strongin, E. Sergienko, M. Pellecchia, 2009, Molecular Cancer Therapeutics.

TRAIL-Based High Throughput Screening Reveals a Link between TRAIL-Mediated Apoptosis and Glutathione Reductase, a Key Component of Oxidative Stress Response

P. Spellman, B. Hann, E. Sergienko, 2015, PloS one.

Centrosomal Pericentrin Is a Direct Cleavage Target of Membrane Type-1 Matrix Metalloproteinase in Humans but Not in Mice

A. Strongin, S. Doxsey, V. Golubkov, 2005, Journal of Biological Chemistry.

A Femtomol Range FRET Biosensor Reports Exceedingly Low Levels of Cell Surface Furin: Implications for the Processing of Anthrax Protective Antigen

A. Strongin, Yingxiao Wang, Mingxing Ouyang, 2010, PloS one.

Internal Cleavages of the Autoinhibitory Prodomain Are Required for Membrane Type 1 Matrix Metalloproteinase Activation, although Furin Cleavage Alone Generates Inactive Proteinase*

A. Strongin, P. Cieplak, Ilian A Radichev, 2010, The Journal of Biological Chemistry.

Inhibition of Membrane Type-1 Matrix Metalloproteinase by Cancer Drugs Interferes with the Homing of Diabetogenic T Cells into the Pancreas*

A. Strongin, F. Wong, D. Rozanov, 2005, Journal of Biological Chemistry.

High-Resolution Analysis and Functional Mapping of Cleavage Sites and Substrate Proteins of Furin in the Human Proteome

A. Strongin, M. Chee, E. Chudin, 2013, PloS one.

Interference with the complement system by tumor cell membrane type-1 matrix metalloproteinase plays a significant role in promoting metastasis in mice.

A. Strongin, D. Rozanov, S. Tomlinson, 2006, Cancer research.

Interaction of Hepatitis B Viral Oncoprotein with Cellular Target HBXIP Dysregulates Centrosome Dynamics and Mitotic Spindle Formation*

A. Strongin, John Calvin Reed, Wei Jiang, 2008, Journal of Biological Chemistry.

Proteolysis-Driven Oncogenesis

A. Strongin, V. Golubkov, 2007, Cell cycle.

PTK7 proteolytic fragment proteins function during early Xenopus development.

D. Frank, V. Golubkov, Naama Bin-Nun, 2019, Developmental biology.

Novel MT1-MMP small-molecule inhibitors based on insights into hemopexin domain function in tumor growth.

A. Strongin, M. Pellecchia, J. Stebbins, 2012, Cancer research.

Insights into Ectodomain Shedding and Processing of Protein-tyrosine Pseudokinase 7 (PTK7)*

A. Strongin, V. Golubkov, 2012, The Journal of Biological Chemistry.

Microarray-based Transcriptional and Epigenetic Profiling of Matrix Metalloproteinases, Collagens, and Related Genes in Cancer*

A. Strongin, Roy M. Williams, E. Snyder, 2010, The Journal of Biological Chemistry.

Mass spectrometry of murine leukemia virus core proteins.

W. Anderson, Roger E. Moore, A. Falick, 2010, Journal of virological methods.

Thermal links for reducing the heat leakage to cryostats

V. Golubkov, N. Pankratov, L. G. Simoshenkova, 1974 .

Immunodominant fragments of myelin basic protein initiate T cell-dependent pain

A. Strongin, V. Shubayev, A. Remacle, 2012, Journal of Neuroinflammation.

The MMP-9/TIMP-1 Axis Controls the Status of Differentiation and Function of Myelin-Forming Schwann Cells in Nerve Regeneration

A. Strongin, A. Mizisin, V. Shubayev, 2012, PloS one.

Anti-Angiogenic Activity of Contortrostatin, a Disintegrin from Agkistrodon Contortrix Contortrix Snake Venom

V. Golubkov, F. Markland, D. Hawes, 2004, Angiogenesis.

A Novel Snake Venom Disintegrin That Inhibits Human Ovarian Cancer Dissemination and Angiogenesis in an Orthotopic Nude Mouse Model

Richard Sposto, R. Sherwin, R. Sposto, 2001, Pathophysiology of Haemostasis and Thrombosis.

Non-proteolytic, Receptor/Ligand Interactions Associate Cellular Membrane Type-1 Matrix Metalloproteinase with the Complement Component C1q*

A. Godzik, A. Strongin, D. Rozanov, 2004, Journal of Biological Chemistry.

Proteolysis of the Membrane Type-1 Matrix Metalloproteinase Prodomain

Jeffrey W. Smith, A. Strongin, Ilian A Radichev, 2007, Journal of Biological Chemistry.

Substrate Cleavage Profiling Suggests a Distinct Function of Bacteroides fragilis Metalloproteinases (Fragilysin and Metalloproteinase II) at the Microbiome-Inflammation-Cancer Interface*

A. Strongin, P. Čapek, P. Cieplak, 2013, The Journal of Biological Chemistry.

The Wnt/Planar Cell Polarity Protein-tyrosine Kinase-7 (PTK7) Is a Highly Efficient Proteolytic Target of Membrane Type-1 Matrix Metalloproteinase

A. Strongin, P. Cieplak, Ilian A Radichev, 2010, The Journal of Biological Chemistry.

Potential Relation of Aberrant Proteolysis of Human Protein Tyrosine Kinase 7 (PTK7) chuzhoi by Membrane Type 1 Matrix Metalloproteinase (MT1-MMP) to Congenital Defects*

A. Strongin, A. Aleshin, V. Golubkov, 2011, The Journal of Biological Chemistry.

Intradomain Cleavage of Inhibitory Prodomain Is Essential to Protumorigenic Function of Membrane Type-1 Matrix Metalloproteinase (MT1-MMP) in Vivo*

A. Strongin, V. Golubkov, Alex Y. Strongin, 2011, The Journal of Biological Chemistry.

Membrane type-1 matrix metalloproteinase confers aneuploidy and tumorigenicity on mammary epithelial cells.

A. Strongin, D. Rozanov, V. Golubkov, 2006, Cancer research.

Downstream signaling and genome-wide regulatory effects of PTK7 pseudokinase and its proteolytic fragments in cancer cells

A. Strongin, V. Golubkov, 2014, Cell Communication and Signaling.

Selective and potent furin inhibitors protect cells from anthrax without significant toxicity.

A. Strongin, R. Liddington, P. Cieplak, 2010, The international journal of biochemistry & cell biology.

Identification of Annexin A4 as a hepatopancreas factor involved in liver cell survival.

A. Strongin, R. G. Correa, V. Golubkov, 2014, Developmental biology.

Membrane Type-1 Matrix Metalloproteinase (MT1-MMP) Exhibits an Important Intracellular Cleavage Function and Causes Chromosome Instability*

A. Strongin, A. Osterman, S. Boyd, 2005, Journal of Biological Chemistry.

A monoclonal antibody interferes with TIMP-2 binding and incapacitates the MMP-2-activating function of multifunctional, pro-tumorigenic MMP-14/MT1–MMP

A. Strongin, P. Cieplak, N. Behrendt, 2013, Oncogenesis.

Biochemical evidence of the interactions of membrane type-1 matrix metalloproteinase (MT1-MMP) with adenine nucleotide translocator (ANT): potential implications linking proteolysis with energy metabolism in cancer cells.

A. Strongin, Ilian A Radichev, Wenhong Zhu, 2009, The Biochemical journal.

The transmembrane domain is essential for the microtubular trafficking of membrane type-1 matrix metalloproteinase (MT1-MMP)

A. Strongin, A. Remacle, D. Rozanov, 2005, Journal of Cell Science.

Both PA63 and PA83 are endocytosed within an anthrax protective antigen mixed heptamer: a putative mechanism to overcome a furin deficiency.

A. Strongin, R. Day, M. Fugère, 2006, Archives of biochemistry and biophysics.

Molecular signature of MT1-MMP: transactivation of the downstream universal gene network in cancer.

Alex Y Strongin, A. Strongin, Roy M. Williams, 2008, Cancer research.

Non-destructive and Selective Imaging of the Functionally Active, Pro-invasive Membrane Type-1 Matrix Metalloproteinase (MT1-MMP) Enzyme in Cancer Cells*

A. Strongin, A. Remacle, V. Golubkov, 2013, The Journal of Biological Chemistry.

Membrane type-1 matrix metalloproteinase (MT1-MMP) protects malignant cells from tumoricidal activity of re-engineered anthrax lethal toxin.

A. Strongin, D. Rozanov, V. Golubkov, 2005, The international journal of biochemistry & cell biology.

Matrix metalloproteinase 26 proteolysis of the NH2-terminal domain of the estrogen receptor beta correlates with the survival of breast cancer patients.

A. Strongin, M. Duffy, S. Krajewski, 2006, Cancer research.

Matrix Metalloproteinase-26 Is Associated with Estrogen-Dependent Malignancies and Targets α1-Antitrypsin Serpin

A. Strongin, S. Krajewski, H. Hedayat, 2004, Cancer Research.

Action of fenretinide (4-HPR) on ovarian cancer and endothelial cells.

V. Golubkov, F. Markland, Agustin Garcia, 2005, Anticancer research.

Timp‐2 binding with cellular MT1‐MMP stimulates invasion‐promoting MEK/ERK signaling in cancer cells

A. Strongin, A. Noel, A. Remacle, 2009, International journal of cancer.

Software for Numerical Calculations of Particle Trajectories in the Earth’s Magnetosphere and Its Use in Processing PAMELA Experimental Data

A. Mayorov, V. Golubkov, 2021, Bulletin of the Russian Academy of Sciences: Physics.

Downstream signaling and genome-wide regulatory effects of PTK7 pseudokinase and its proteolytic fragments in cancer cells

A. Strongin, V. Golubkov, 2014, Cell Communication and Signaling.

1 Proteolysis of the membrane type-1 matrix metalloproteinase ( MT 1-MMP ) prodomain : implications for a two-step proteolytic processing and activation

Jeffrey W. Smith, A. Strongin, Ilian A Radichev, 2007 .